News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
371,084 Results
Type
Article (15550)
Company Profile (128)
Press Release (355406)
Section
Business (113747)
Career Advice (492)
Deals (18760)
Drug Delivery (28)
Drug Development (36851)
Employer Resources (51)
FDA (9600)
Job Trends (8162)
News (180162)
Policy (13099)
Tag
Academia (1367)
Alliances (34887)
Alzheimer's disease (479)
Approvals (9596)
Artificial intelligence (147)
Bankruptcy (129)
Best Places to Work (7003)
Biotechnology (95)
Breast cancer (107)
Cancer (863)
Career advice (441)
CAR-T (75)
Cell therapy (206)
Clinical research (29141)
Collaboration (365)
Compensation (67)
COVID-19 (1182)
C-suite (72)
Data (814)
Diabetes (61)
Diagnostics (4794)
Earnings (38672)
Events (52252)
Executive appointments (218)
FDA (9980)
Funding (276)
Gene therapy (114)
GLP-1 (208)
Government (1368)
Healthcare (10135)
Infectious disease (1236)
IPO (8039)
Job creations (1461)
Job search strategy (397)
Layoffs (115)
Legal (2528)
Lung cancer (132)
Lymphoma (67)
Manufacturing (129)
Medical device (11379)
Medtech (11384)
Mergers & acquisitions (10859)
Metabolic disorders (152)
Neuroscience (605)
NextGen Class of 2024 (3593)
Non-profit (1575)
Northern California (839)
Obesity (71)
Opinion (72)
Patents (73)
People (32424)
Phase I (10068)
Phase II (13083)
Phase III (9188)
Pipeline (273)
Postmarket research (704)
Preclinical (4152)
Press Release (66)
Radiopharmaceuticals (161)
Rare diseases (122)
Real estate (3371)
Regulatory (9811)
Research institute (1317)
Resumes & cover letters (70)
Southern California (820)
Startups (2504)
United States (8216)
Vaccines (263)
Date
Today (16)
Last 7 days (328)
Last 30 days (1277)
Last 365 days (19895)
2024 (19792)
2023 (23246)
2022 (31930)
2021 (33709)
2020 (31577)
2019 (26680)
2018 (20060)
2017 (19512)
2016 (18263)
2015 (21174)
2014 (15523)
2013 (12943)
2012 (14032)
2011 (14323)
2010 (13029)
Location
Africa (326)
Arizona (98)
Asia (24516)
Australia (4226)
California (1998)
Canada (794)
China (174)
Colorado (118)
Connecticut (95)
Europe (50144)
Florida (296)
Georgia (93)
Illinois (209)
Indiana (123)
Japan (62)
Kansas (76)
Maryland (337)
Massachusetts (1418)
Michigan (151)
Minnesota (191)
New Hampshire (59)
New Jersey (667)
New York (577)
North Carolina (425)
Northern California (839)
Ohio (81)
Pennsylvania (405)
South America (521)
Southern California (820)
Texas (316)
Utah (66)
Washington State (248)
371,084 Results for "median technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Median Technologies to Host Key Opinion Leader (KOL) Webinar on AI and Lung Cancer Screening
October 30, 2024
·
6 min read
Press Releases
Median Technologies to Showcase AI-Powered Lung Cancer Diagnostic eyonis™ LCS at the Radiological Society of North America (RSNA) 2024
November 26, 2024
·
5 min read
Business
Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”) today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited) for the first quarter of 2024, as of March 31, 2024.
April 25, 2024
·
12 min read
Median Technologies to Participate in the 2024 ASCO Annual Meeting, May 31 - June 4, 2024, McCormick Place, Chicago, IL, USA
Median Technologies announced that the Company will be participating in the 2024 American Society of Clinical Oncology Annual Meeting taking place from May 31 to June 4, McCormick Place, Chicago, IL, USA.
May 29, 2024
·
2 min read
Business
Median Technologies Reports 2024 Q3 Operational and Financial Update and 2024 Half-Year Results
October 24, 2024
·
14 min read
Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company
Regulatory News: Median Technologies announced that the Company has been selected as preferred vendor by a Top 3 pharmaceutical company, adding another one of the largest global pharmaceutical companies to its client portfolio.
May 21, 2024
·
3 min read
Business
Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook
Median Technologies announces its 2023 revenue, outlining both its strategic outlook and key milestones for 2024.
January 29, 2024
·
10 min read
Median Technologies to Participate in the TD Cowen’s 44th Annual Health Care Conference
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) (Paris:ALMDT), will be participating in the TD Cowen’s 44th Annual Health Care Conference, taking place on March 4 – 6 ,2024, at the Boston Marriott Copley Place in Boston, MA, USA.
February 29, 2024
·
2 min read
Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria
Median Technologies announces that the Company will be participating and speaking at the premier European radiology conference, the European Congress of Radiology, being held in Vienna, Austria, February 28 – March 3, 2024.
February 26, 2024
·
3 min read
Median Technologies Announces Rebranding of iBiopsy®, Changes Name to eyonis™
Median Technologies unveils a new identity, including a new name, logo, tagline for its iBiopsy® AI/ML tech-based suite of software as medical devices and business unit, as part of an extensive rebranding initiative.
November 26, 2023
·
3 min read
1 of 37,109
Next
